http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TR-199902094-T2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c860d4ae46e1f3d8fdc898d87fac24e5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-10
filingDate 1998-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0994caa1d2656c094168efc3efa0940e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a26b1234d12a7001688bc88fa7db7806
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77f05460e40ba5730ab37a486448f15b
publicationDate 1999-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TR-199902094-T2
titleOfInvention Atropisomers of 3-Heteroareil-4 (3H) -quinazolinones.
abstract This invention relates to new atropisomers of 3-heteroaryl, the formula of which is formula (1a), their pharmaceutical acceptable salts, pharmaceutical compounds and methods for the treatment of neurodegenerative and CNS-traumatic conditions. Formula (Ia).
priorityDate 1997-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421360260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID344381

Total number of triples: 32.